Hepatology

Filter

Immunosuppressive Therapy May Drive AIH Recompensation

May 2026

Patients with autoimmune hepatitis (AIH) and decompensated cirrhosis achieved AIH recompensation following immunosuppressive therapy in a retrospective cohort study.

Immunosuppressive Therapy May Drive AIH Recompensation

Patients with autoimmune hepatitis (AIH) and decompensated cirrhosis achieved AIH recompensation following immunosuppressive therapy in a retrospective cohort study.

RAAS Inhibitors Lower Liver Cancer Risk in MASLD - EMJ

RAAS Inhibitors in MASLD Linked to Lower Liver Cancer Risk

RAAS inhibitor use in MASLD is linked to lower hepatocellular carcinoma risk in a large Taiwan cohort. Find out more from the study findings.

Quantitative MRCP Enhances PSC Risk Prediction

Quantitative MRCP may improve risk prediction and clinical trial development in primary sclerosing cholangitis, an international study suggests.

Rural Hepatocellular Carcinoma Rates Rise as Urban Trends Decline

Rural HCC incidence increased between 2001 and 2022 while urban rates declined, highlighting widening disparities in liver cancer care.

Liver Disease Stigma Scale Validated in ALD Study - EMJ

New Liver Disease Stigma Scale Validated in Study

Researchers validate the Liver Disease Stigma Scale, showing higher stigma in alcohol-associated liver disease compared with non-ALD cases.

HCC Brain Metastases Survival Still Short Despite Advances

Brain metastases from HCC remain rare, but selected patients receiving local therapy showed markedly longer survival in a retrospective study.

T2 MRI Differentiates Neonatal Haemochromatosis from Liver Failure

Multi-echo T2* MRI distinguishes neonatal haemochromatosis from other neonatal liver failure causes by detecting thyroid and pancreatic iron deposition.

Tacrolimus Improves Liver Transplant Survival

Tacrolimus was linked to lower mortality and rejection after liver transplantation, but carried a higher risk of diabetes.

Loading posts...

1 2 3 … 48 Next »